APA (7th ed.) Citation

JRE, C., YH, J., SGW, O., A, W., MX, L., N, N., . . . SC, L. (2022). Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors. Targeted oncology, 17(3), 355. https://doi.org/10.1007/s11523-022-00886-x

Chicago Style (17th ed.) Citation

JRE, Choo, et al. "Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors." Targeted Oncology 17, no. 3 (2022): 355. https://doi.org/10.1007/s11523-022-00886-x.

MLA (9th ed.) Citation

JRE, Choo, et al. "Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors." Targeted Oncology, vol. 17, no. 3, 2022, p. 355, https://doi.org/10.1007/s11523-022-00886-x.